GALAXY THERAPEUTICS, LLC

San Jose, CA · Founded 2020 · Medtech · Private

Biological therapeutics for brain aneurysm treatment

Claim this profile

Follows are private to you and power your alerts

Updated · galaxytherapeutics.com

Sector
Medtech
Headquarters
San Jose, CA
Founded
2020
Latest Form D
$3M, Jul 2024
Total capital
$13.3M
Federal grants
$256K
1 award · 2021
Rank in peer group#169 of 542
Private capital raised
$13M
4 Form D · last Jul 2024
27 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
2 pending · first 2018
Rank in peer group#81 of 542

Capital timeline

20202021202220232024FEDERAL ↑EQUITY ↓Cumulative $13.3M$256K1st Form D$325K2nd Form D$7.6M
20202021202220232024FEDERAL ↑EQUITY ↓Cumulative $13.3M$256K2nd Form D$7.6M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$3M
  • Private capital raisedForm D · SEC · 3rd filing$2.1M
  • Private capital raisedForm D · SEC · 2nd filing$7.6M
  • Federal grantNSF · Phase I · SBIR Phase I: A Versatile Endovascular Lattice for the Treatment of Saccular Aneurysms$256K
  • Private capital raisedForm D · SEC · 1st filing$325K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grants#169 · top 31%
  • Granted patents#81 · top 15%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • AAMIR BADRUDDINResearcherExecutive Officer, DirectorLinked by 2 patents
  • OSAMA ZAIDATResearcherExecutive Officer, DirectorLinked by $256K in grants as PI
  • EDGARD PEREIRAExecutive Officer, DirectorNamed in SEC Form D filings
  • THOMAS WOLFEExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 4
Show all 4 patent records
  • Diagnostic anSERS Inc.Similar federal contract value in Medtech · null in contracts
  • Atantares CorpSimilar federal contract value in Medtech · null in contracts
  • NEUROBIONICS INCSimilar federal contract value in Medtech · null in contracts
  • Avisi Technologies, IncSimilar federal contract value in Medtech · null in contracts
  • CAIRA SURGICAL CORPSimilar federal contract value in Medtech · null in contracts
  • J3 BIOSCIENCE, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .